A company selling a version of an anti-retroviral drug used in the treatment of people living with HIV/AIDS is breaching the Irish patent for the product, it is claimed.

Senior executives in many of Ireland’s leading pharma, life sciences and technology companies did ordinary level maths in their Leaving Certificate.

Much like the persistence of racism, to be still talking about a problem that existed in the days when Graeme Souness had a moustache and a perm feels like a depressing indictment of humanity’s inability to change for the better, writes Tommy Martin.